Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may incre···【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 117
Follow your doctor's instructions about any restrictions on food, beverages, or activity.【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 119
Alpelisib is a targeted therapy directed against PIK3CA mutations, developed by Novartis Pharmaceuticals of Switzerland. This article provides a detai···【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 117
Alpelisib is a targeted therapy for specific types of breast cancer. The drug is not yet approved in mainland China and is not covered by medical insu···【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 106
Novartis announced the final overall survival (OS) analysis results from the phase III SOLAR‑1 study of Piqray (alpelisib), a novel breast cancer ther···【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 120
Novartis recently announced the final overall survival (OS) analysis results of the phase III SOLAR-1 study of the new breast cancer drug Piqray (alpe···【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 111
EU Approval Details of PiqrayNovartis recently announced that the European Commission (EC) has approved Piqray (alpelisib) in combination with fulvest···【Read More】
Update: 2026-03-02Source: Haiou HealthViews: 111
Cabozantinib is a broad-spectrum, multi-target anti-tumor drug developed by Exelixis Biopharmaceuticals, Inc. While most anti-tumor drugs target 1-3 t···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 129
On March 26, 2025, Exelixis announced that the U.S. Food and Drug Administration (FDA) has approved cabozantinib (Cabometyx) for the treatment of two ···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 106
Cabozantinib is a small-molecule, multi-target tyrosine kinase inhibitor developed by Exelixis in the United States. In November 2012, the FDA first a···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 133
Cabozantinib is a broad-spectrum anticancer drug targeting multiple targets, inhibiting at least nine targets including MET, VEGFR1/2/3, ROS1, RET, AX···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 116
Valganciclovir is an antiviral medication used for the treatment of cytomegalovirus (CMV) infections, with widespread application particularly in pati···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 118
Valganciclovir (Valcyte) is a key antiviral drug for the treatment and prevention of cytomegalovirus (CMV) infections, especially indicated for CMV re···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 127
Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 123
Valcyte can harm your kidneys,especially if you also use certain medicines for infections, cancer,osteoporosis, organ transplant rejection, bowel diso···【Read More】
Update: 2026-02-28Source: Haiou HealthViews: 125
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos